I make a donation

A randomized controlled trial on mavacamten, a myosin inhibitor in patients with obstructive hypertrophic cardiomyopathy

Mavacamten - Hypertrophic cardiomyopathy

Colloquium "La cardiologie préventive : nouveautés" (mardi 1er avril 2025)
Réservez vos places !

Publication presented by Thibault REMY

On July 12, 2022

Title: Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy

18/02/2025

ICD - Ventricular tachycardia - Antiarrhythmic drugs

11/02/2025

AF - Electroporation - PVI

28/01/2025

AVR - Aortic Stenosis - HF